These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35452459)

  • 21. Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries.
    Ragonnet R; Trauer JM; Geard N; Scott N; McBryde ES
    BMC Med; 2019 Nov; 17(1):208. PubMed ID: 31752895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study.
    Abbas KM; van Zandvoort K; Brisson M; Jit M
    Lancet Glob Health; 2020 Apr; 8(4):e536-e544. PubMed ID: 32105613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and Safety of the M72/AS01
    Ji Z; Jian M; Chen T; Luo L; Li L; Dai X; Bai R; Ding Z; Bi Y; Wen S; Zhou G; Abi ME; Liu A; Bao F
    Front Immunol; 2019; 10():2089. PubMed ID: 31552037
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
    Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
    BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem.
    Styblo K; Meijer J
    Tubercle; 1976 Mar; 57(1):17-43. PubMed ID: 1085050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California.
    Menzies NA; Parriott A; Shrestha S; Dowdy DW; Cohen T; Salomon JA; Marks SM; Hill AN; Winston CA; Asay GR; Barry P; Readhead A; Flood J; Kahn JG; Shete PB
    Am J Respir Crit Care Med; 2020 Feb; 201(3):356-365. PubMed ID: 31626560
    [No Abstract]   [Full Text] [Related]  

  • 27. Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.
    Weerasuriya CK; Harris RC; Quaife M; McQuaid CF; White RG; Gomez GB
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33799544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estimation of the future epidemiological situation of tuberculosis in Japan].
    Ohmori M; Yoshiyama T; Ishikawa N
    Kekkaku; 2008 Apr; 83(4):365-77. PubMed ID: 18516900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial.
    Kumarasamy N; Poongulali S; Beulah FE; Akite EJ; Ayuk LN; Bollaerts A; Demoitié MA; Jongert E; Ofori-Anyinam O; Van Der Meeren O
    Medicine (Baltimore); 2018 Nov; 97(45):e13120. PubMed ID: 30407329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 2b Controlled Trial of M72/AS01
    Van Der Meeren O; Hatherill M; Nduba V; Wilkinson RJ; Muyoyeta M; Van Brakel E; Ayles HM; Henostroza G; Thienemann F; Scriba TJ; Diacon A; Blatner GL; Demoitié MA; Tameris M; Malahleha M; Innes JC; Hellström E; Martinson N; Singh T; Akite EJ; Khatoon Azam A; Bollaerts A; Ginsberg AM; Evans TG; Gillard P; Tait DR
    N Engl J Med; 2018 Oct; 379(17):1621-1634. PubMed ID: 30280651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age-period-cohort analysis.
    Dhamnetiya D; Patel P; Jha RP; Shri N; Singh M; Bhattacharyya K
    BMC Pulm Med; 2021 Nov; 21(1):375. PubMed ID: 34784911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis.
    Dowdy DW; Basu S; Andrews JR
    Am J Respir Crit Care Med; 2013 Mar; 187(5):543-51. PubMed ID: 23262515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical model to assess vaccination and effective contact rate impact in the spread of tuberculosis.
    Nkamba LN; Manga TT; Agouanet F; Mann Manyombe ML
    J Biol Dyn; 2019 Dec; 13(1):26-42. PubMed ID: 31793413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
    Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
    BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis.
    Denkinger CM; Kampmann B; Ahmed S; Dowdy DW
    BMC Infect Dis; 2014 Sep; 14():477. PubMed ID: 25186052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study.
    Abbott S; Christensen H; Brooks-Pollock E
    BMJ Open; 2022 Jan; 12(1):e031573. PubMed ID: 35017227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-level impact of active tuberculosis case finding in an Asian megacity.
    Dowdy DW; Lotia I; Azman AS; Creswell J; Sahu S; Khan AJ
    PLoS One; 2013; 8(10):e77517. PubMed ID: 24147015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final Analysis of a Trial of M72/AS01
    Tait DR; Hatherill M; Van Der Meeren O; Ginsberg AM; Van Brakel E; Salaun B; Scriba TJ; Akite EJ; Ayles HM; Bollaerts A; Demoitié MA; Diacon A; Evans TG; Gillard P; Hellström E; Innes JC; Lempicki M; Malahleha M; Martinson N; Mesia Vela D; Muyoyeta M; Nduba V; Pascal TG; Tameris M; Thienemann F; Wilkinson RJ; Roman F
    N Engl J Med; 2019 Dec; 381(25):2429-2439. PubMed ID: 31661198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.
    Houben RMGJ; Menzies NA; Sumner T; Huynh GH; Arinaminpathy N; Goldhaber-Fiebert JD; Lin HH; Wu CY; Mandal S; Pandey S; Suen SC; Bendavid E; Azman AS; Dowdy DW; Bacaër N; Rhines AS; Feldman MW; Handel A; Whalen CC; Chang ST; Wagner BG; Eckhoff PA; Trauer JM; Denholm JT; McBryde ES; Cohen T; Salomon JA; Pretorius C; Lalli M; Eaton JW; Boccia D; Hosseini M; Gomez GB; Sahu S; Daniels C; Ditiu L; Chin DP; Wang L; Chadha VK; Rade K; Dewan P; Hippner P; Charalambous S; Grant AD; Churchyard G; Pillay Y; Mametja LD; Kimerling ME; Vassall A; White RG
    Lancet Glob Health; 2016 Nov; 4(11):e806-e815. PubMed ID: 27720688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.